Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The term nociception was originally defined by Sherrington1 as the neural process by which high-threshold stimuli (which cause tissue injury) are detected. This is distinct from pain, which is defined by the quality of the sensory percept (i.e., unpleasant), is not always evoked by a noxious stimulus, and can also be experienced in the absence of a noxious stimulus. In man, recessive loss of function mutations in the SCN9A gene, encoding the α subunit of Nav1.7, results in anosmia and the congenital inability to experience pain,2–4 but there have been few reports of detailed sensory testing in these patients.

Original publication

DOI

10.1212/WNL.0000000000000913

Type

Journal article

Journal

Neurology

Publisher

American Academy of Neurology

Publication Date

21/10/2014